Please login to the form below

Not currently logged in
Email:
Password:

Innovative Medicines Initiative appoints executive director

Pierre Meulien joins from Genome Canada 

edit-Innovative-Medicines-Initiative-pierre-meulienInnovative Medicines Initiative (IMI) has named Pierre Meulien as executive director, effective from September.

Meulien is currently president and CEO of Genome Canada, a not-for-profit organisation that aims to find new uses for genomics. At the organisation, he successfully secured funding from the Canadian government and leveraged further funding through partnerships.

Commenting on his appointment, Meulien said: “I am delighted to have been selected to lead the second phase of the Innovative Medicines Initiative. 

“This unique joint venture will deliver health innovations to millions of European citizens and solidify an important industry based in Europe that will be a source of jobs and growth in all of the member states.”

Prior to joining Genome Canada in 2010, Meulien served as CSO for Genome British Columbia, where he promoted the organisation's scientific strategy, and prior to that was founding CEO of the Dublin Molecular Medicine Centre.

Carlos Moedas, European commissioner for research, science and innovation, said: “The excellent results coming out of IMI's projects contribute to improving public health and are stimulating innovation and job creation in Europe. Pierre Meulien's invaluable experience will help IMI deliver on its ambitious objectives.”

22nd June 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics